KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 74 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $241,000 | +63.9% | 19,947 | +3.6% | 0.01% | +16.7% |
| Q1 2020 | $147,000 | -58.7% | 19,261 | -3.7% | 0.01% | 0.0% |
| Q4 2019 | $356,000 | -43.1% | 20,000 | -63.0% | 0.01% | -53.8% |
| Q3 2019 | $626,000 | -47.7% | 54,000 | 0.0% | 0.01% | -59.4% |
| Q2 2019 | $1,196,000 | -22.6% | 54,000 | 0.0% | 0.03% | -15.8% |
| Q1 2019 | $1,545,000 | +90.7% | 54,000 | +31.7% | 0.04% | +11.8% |
| Q4 2018 | $810,000 | -8.4% | 41,000 | +2.5% | 0.03% | +47.8% |
| Q3 2018 | $884,000 | – | 40,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
| VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
| Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
| VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
| Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
| ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
| Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
| Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |